心房細動治療の世界市場2023~2028:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書(IMARC23NOV166)◆商品コード:IMARC23NOV166
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年10月
◆ページ数:145
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

市場概要世界の心房細動治療市場規模は2022年に70億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて11.73%の成長率(CAGR)を示し、2028年までに137億米ドルに達すると予測しています。

心房細動(AFib)とは、心拍数が不規則で速く、脳卒中、心不全、その他の心臓関連合併症のリスクを高める心臓疾患のことです。心房細動では、心房上部の心室と心室下部の心室が不規則に拍動し、動悸、息切れ、疲労感を引き起こします。また、血栓ができやすくなり、他の臓器への血流が妨げられることもあります。心房細動の主な種類には、発作性心房細動、持続性心房細動、長期持続性心房細動、永続性心房細動があり、薬物療法や心臓の電気インパルスを調整するその他の介入によって治療することができます。

心血管疾患(CVDs)の有病率の上昇は、市場の成長を促進する重要な要因の一つです。このような疾患は、老年人口や、糖尿病、高血圧、心血管疾患(CVDs)などの他の病気を患っている人々の間で非常に普及しています。これは、世界中で着実に増加している老年人口とともに、市場の成長を後押ししています。さらに、低侵襲(MI)手術への嗜好の高まりも、小型化手術装置、インプラント手術、遠隔看護の需要に好影響を与えています。さらに、損傷した心臓組織を除去するためのカテーテルアブレーション装置や革新的なマッピング・記録システムの開発など、さまざまな技術的進歩も成長を促す要因となっています。その他、医療インフラの改善や医療科学分野における広範な研究開発(R&D)活動なども、市場をさらに牽引すると予測されます。

主な市場セグメンテーション
IMARC Groupは、世界の心房細動治療市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年にかけての世界、地域、国レベルでの予測を提供しています。当レポートでは、疾患タイプ、治療タイプ、エンドユーザーに基づいて市場を分類しています。

疾患タイプ別内訳
発作性心房細動
持続性心房細動
永続性心房細動
その他

治療タイプ別内訳
医療処置
外科的処置
メイズ手術
カテーテルアブレーション
非外科的治療
電気的除細動
診断用カテーテル
マッピングおよび記録システム
心臓モニター
アクセス機器
左心房付属器および閉鎖装置
心エコー(ICE)システム
薬物療法
抗凝固薬
抗不整脈薬

エンドユーザー別内訳
病院
心臓研究所
外来外科センター
その他

地域別内訳
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争状況
当レポートでは、市場の競争環境についても分析しており、主要企業として、Abbott Laboratories、Atricure Inc.、Biotronik、Boston Scientific Corporation、Cardiofocus Inc.、Hansen Medical Inc. (Auris Health)、Johnson & Johnson、Siemens Healthineers、Stereotaxis Inc.などが挙げられます。

本レポートで扱う主な質問
世界の心房細動治療市場はこれまでどのように推移してきたか?
COVID-19が世界の心房細動治療市場に与えた影響は?
主要な地域市場は?
障害タイプに基づく市場の内訳は?
治療タイプに基づく市場の内訳は?
エンドユーザーに基づく市場の内訳は?
業界のバリューチェーンにおける様々な段階とは?
業界の主要な推進要因と課題は何ですか?
世界の心房細動治療市場の構造と主要プレイヤーは?
業界における競争の程度は?

1 序論
2 範囲・方法
3 エグゼクティブサマリー
4 イントロダクション
5 心房細動治療の世界市場
6 心房細動治療の世界市場:疾患タイプ別分析
7 心房細動治療の世界市場:治療タイプ別分析
8 心房細動治療の世界市場:エンドユーザー別分析
9 心房細動治療の世界市場:地域別分析
10 SWOT分析
11 バリューチェーン分析
12 ポーターズファイブフォース分析
13 競争状況

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Atrial Fibrillation Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disorder Type
6.1 Paroxysmal Atrial Fibrillation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Persistent Atrial Fibrillation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Permanent Atrial Fibrillation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Medical Procedures
7.1.1 Market Trends
7.1.2 Surgical Procedures
7.1.2.1 Maze Surgery
7.1.2.2 Catheter Ablation
7.1.3 Non-Surgical Devices
7.1.3.1 Electric Cardioversion
7.1.3.2 Diagnostic Catheters
7.1.3.3 Mapping and Recording Systems
7.1.3.4 Cardiac Monitors
7.1.3.5 Access Devices
7.1.3.6 Left Atrial Appendage and Closure Devices
7.1.3.7 Intracardiac Echocardiography (ICE) Systems
7.1.4 Market Forecast
7.2 Medications
7.2.1 Market Trends
7.2.2 Drug Class
7.2.2.1 Anticoagulants
7.2.2.2 Anti-Arrhythmics
7.2.3 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiac Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgical Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Atricure Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biotronik
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Boston Scientific Corporation
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 Cardiofocus Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Hansen Medical Inc. (Auris Health)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Johnson & Johnson
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Siemens Healthineers
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Stereotaxis Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis

Figure 1: Global: Atrial Fibrillation Treatment Market: Major Drivers and Challenges
Figure 2: Global: Atrial Fibrillation Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Atrial Fibrillation Treatment Market: Breakup by Disorder Type (in %), 2022
Figure 4: Global: Atrial Fibrillation Treatment Market: Breakup by Treatment Type (in %), 2022
Figure 5: Global: Atrial Fibrillation Treatment Market: Breakup by End-User (in %), 2022
Figure 6: Global: Atrial Fibrillation Treatment Market: Breakup by Region (in %), 2022
Figure 7: Global: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Atrial Fibrillation Treatment (Medical Procedures) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Atrial Fibrillation Treatment Market (Medical Procedures): Breakup by Type (in %), 2022
Figure 18: Global: Atrial Fibrillation Treatment Market (Surgical Procedures): Breakup by Type (in %), 2022
Figure 19: Global: Atrial Fibrillation Treatment (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Atrial Fibrillation Treatment (Medication) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Atrial Fibrillation Treatment Market (Medication): Breakup by Drug Classes (in %), 2022
Figure 22: Global: Atrial Fibrillation Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Atrial Fibrillation Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Atrial Fibrillation Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia Pacific: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia Pacific: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Atrial Fibrillation Treatment Industry: SWOT Analysis
Figure 80: Global: Atrial Fibrillation Treatment Industry: Value Chain Analysis
Figure 81: Global: Atrial Fibrillation Treatment Industry: Porter’s Five Forces Analysis

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心房細動治療の世界市場2023~2028:産業動向、シェア、規模、成長、機会・予測(Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆